Clomiphene for the Treatment of Male Infertility: A Case Report of Mood Change and a Literature Overview

Author(s): Marine Aussedat, Jennifer Jean-Louis, Orchidee Djahangirian, Marie-Sophie Brochet*

Journal Name: Current Drug Safety

Volume 12 , Issue 3 , 2017


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Clomiphene is normally used in women with ovulatory dysfunction. In men, it is used off label in some cases of infertility. Psychological adverse effects are reported in women but very few in men.

Case: A 34-year-old man treated with clomiphene for oligoteratospermia presented anxiety, decreased appetite, and mood change making him unable to function properly at work, five days after initiation of therapy. Symptoms required reduction followed by discontinuation of treatment four days later because of absence of improvement. Following cessation, the patient noted a gradual then a complete resolution approximately one week later. The patient did not have any psychiatric or other medical condition neither drug nor substance abuse that could explain this clinical presentation. The Naranjo's score was used to prove the clomiphene's imputability.

Conclusion: Health care providers should advise patients of the risk of psychological adverse effects when initiating treatment with clomiphene and should provide a close monitoring of mood change, especially during the initial weeks.

Keywords: Anxiety, clomiphene, drug-related side effects and adverse reactions, infertility, male, mood disorders.

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 12
ISSUE: 3
Year: 2017
Published on: 02 October, 2017
Page: [208 - 215]
Pages: 8
DOI: 10.2174/1574886312666170616092036
Price: $65

Article Metrics

PDF: 23
HTML: 3